Build a Winning Business Case for a Lung Cancer Nurse
Lung cancer remains a leading cause of death, and nurses specialising in this area play a critical role in patient care. However, securing funding for a new Lung Cancer Clinical Nurse Specialist (CNS) position requires a persuasive business case.
How HeSANDA is Revolutionising Australian Medical Research
How HeSANDA is Revolutionising Australian Medical Research Imagine a world where medical research doesn’t have to start from scratch. Imagine a treasure trove of valuable data readily available to answer new questions and fuel groundbreaking discoveries. This is the reality HeSANDA, the Health Studies Australian National Data Asset, is creating for Australian researchers. HeSANDA: More […]
Beyond the Myths: Unveiling the Truth About Clinical Trials for Lung Cancer
Have you been diagnosed with lung cancer and are overwhelmed by treatment options?
You might have come across the term “clinical trials” and are unsure if they’re the right path for you. Many misconceptions surround clinical trials, leaving you hesitant. But what if these trials could be the key to unlocking the best possible treatment for your specific condition?
OCEANiC: TOGA’s New Trial Open to Recruitment
What is OCEANiC? The TOGA OCEANIC study follows on from the ADAURA study which showed a significant improvement in DFS and OS compared to placebo. OCEANiC will provide free access to a TKI inhibitor and aims to evaluate if chemotherapy can be omitted in patients with EGFR mutant NSCLC who are at low risk of […]
Five Things to Consider When Participating in a Clinical Trial
Facing a diagnosis can be a daunting journey, rife with uncertainty and difficult decisions. Among these decisions is the choice of whether to participate in a clinical trial. While the prospect may initially seem overwhelming, it’s essential to recognise the potential benefits and weigh them against the uncertainties. In this guide, we’ll explore five critical […]
Three Reasons You Should Participate in Clinical Trials
In the realm of medical breakthroughs, cancer clinical trials emerge as beacons of hope, guiding us toward innovative treatments and potential cures. These trials represent the frontlines of cancer research, where groundbreaking therapies are meticulously tested before reaching the hands of people living with lung cancer. So, what exactly do these trials entail? Cancer clinical […]
ASM23 highlights
“Shifting The Dial Forward in Lung Cancer Care: It Takes a village” Highlights of the 2023 Annual Scientific Meeting The TOGA 2023 Annual Scientific Meeting highlighted that it truly takes a village to treat lung cancer as it showcased the latest research in immuno- and targeted therapy, thoracic surgery, respiratory medicine, palliative and supportive care […]
Lung Cancer Screening Program: Early Detection Saves Lives
On May 2, 2023, the Australian Government announced a significant investment of $263.8 million over four years to establish the national Lung Cancer Screening Program (LCSP). This program aims to improve early detection of lung cancer, the leading cause of cancer death in Australia.
MSAC Recommendation for NGS panel testing
Recommendation for improved genetic testing for Non-Small Cell Lung Cancer Patients Recommendation by the Medical Services Advisory Committee (MSAC) Why is gene testing important for lung cancer patients? Non-small cell lung cancer (NSCLC) accounts for about 80% to 85% of lung cancers. The main subtypes of NSCLC are adenocarcinoma, squamous cell carcinoma, or large undifferentiated […]
ASM 2023 Program
Submit an Abstract Back to 2023 ASM ASM 2023 Program We are pleased to announce that the following speakers have confirmed their participation in the TOGA ASM 2023. We are delighted that the two international speakers, Professors Karen Kelly and Stephen Swisher, have accepted our invitations and will be joining us in-person at the TOGA […]
